Narwhal Capital Management’s Elevance Health ELV Stock Holding History

Narwhal Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206K	Sell	532 -946	-64%	-$351K	0.01%	153
2026 Q1	$433K	Hold	1,478	–	–	0.03%	131
2025 Q4	$518K	Hold	1,478	–	–	0.04%	123
2025 Q3	$478K	Sell	1,478 -1,897	-56%	-$590K	0.04%	126
2025 Q2	$1.31M	Sell	3,375 -300	-8%	-$121K	0.11%	93
2025 Q1	$1.6M	Sell	3,675 -600	-14%	-$241K	0.14%	89
2024 Q4	$1.58M	Sell	4,275 -650	-13%	-$272K	0.14%	89
2024 Q3	$2.56M	Sell	4,925 -3,253	-40%	-$1.74M	0.23%	72
2024 Q2	$4.43M	Sell	8,178 -410	-5%	-$217K	0.42%	57
2024 Q1	$4.45M	Sell	8,588 -1,000	-10%	-$497K	0.44%	56
2023 Q4	$4.52M	Hold	9,588	–	–	0.49%	53
2023 Q3	$4.17M	Sell	9,588 -4	-0%	-$1.81K	0.51%	52
2023 Q2	$4.26M	Sell	9,592 -100	-1%	-$46.1K	0.5%	55
2023 Q1	$4.46M	Hold	9,692	–	–	0.56%	50
2022 Q4	$4.97M	Sell	9,692 -30	-0.3%	-$15.2K	0.66%	44
2022 Q3	$4.42M	Hold	9,722	–	–	0.64%	47
2022 Q2	$4.69M	Hold	9,722	–	–	0.64%	46
2022 Q1	$4.78M	Hold	9,722	–	–	0.56%	50
2021 Q4	$4.51M	Hold	9,722	–	–	0.51%	55
2021 Q3	$3.62M	Hold	9,722	–	–	0.46%	56
2021 Q2	$3.71M	Sell	9,722 -250	-3%	-$95.5K	0.47%	59
2021 Q1	$3.58M	Sell	9,972 -2,000	-17%	-$643K	0.48%	56
2020 Q4	$3.84M	Sell	11,972 -1,800	-13%	-$552K	0.54%	51
2020 Q3	$3.7M	Sell	13,772 -500	-4%	-$135K	0.6%	52
2020 Q2	$3.75M	Hold	14,272	–	–	0.65%	49
2020 Q1	$3.24M	Sell	14,272 -1,238	-8%	-$337K	0.7%	47
2019 Q4	$4.68M	Hold	15,510	–	–	0.86%	40
2019 Q3	$3.72M	Sell	15,510 -2,425	-14%	-$664K	0.75%	44
2019 Q2	$5.06M	Sell	17,935 -40	-0.2%	-$10.9K	1.05%	34
2019 Q1	$5.16M	Sell	17,975 -285	-2%	-$82.4K	1.12%	31
2018 Q4	$4.8M	Sell	18,260 -1,050	-5%	-$289K	1.19%	30
2018 Q3	$5.29M	Hold	19,310	–	–	1.17%	23
2018 Q2	$4.6M	Hold	19,310	–	–	1.07%	28
2018 Q1	$4.24M	Sell	19,310 -1,500	-7%	-$352K	0.98%	34
2017 Q4	$4.68M	Sell	20,810 -2,500	-11%	-$532K	1.08%	29
2017 Q3	$4.43M	Sell	23,310 -550	-2%	-$105K	1.1%	27
2017 Q2	$4.49M	Buy	23,860 +400	+2%	+$71.9K	1.16%	23
2017 Q1	$3.88M	Sell	23,460 -240	-1%	-$38.2K	1.08%	27
2016 Q4	$3.41M	Sell	23,700 -350	-1%	-$46.9K	1.03%	29
2016 Q3	$3.01M	Buy	24,050 +150	+0.6%	+$19.4K	0.94%	31
2016 Q2	$3.14M	Hold	23,900	–	–	0.99%	29
2016 Q1	$3.32M	Sell	23,900 -100	-0.4%	-$13.4K	1.08%	25
2015 Q4	$3.35M	Buy	24,000 +1,875	+8%	+$258K	1.16%	21
2015 Q3	$3.1M	Hold	22,125	–	–	1.16%	24
2015 Q2	$3.63M	Hold	22,125	–	–	1.32%	20
2015 Q1	$3.42M	Hold	22,125	–	–	1.25%	21
2014 Q4	$2.78M	Buy	22,125 +975	+5%	+$120K	1.08%	26
2014 Q3	$2.53M	Hold	21,150	–	–	1.02%	28
2014 Q2	$2.28M	Sell	21,150 -800	-4%	-$82.4K	0.87%	36
2014 Q1	$2.19M	Sell	21,950 -3,000	-12%	-$271K	0.91%	31
2013 Q4	$2.31M	Hold	24,950	–	–	0.95%	29
2013 Q3	$2.09M	Sell	24,950 -2,100	-8%	-$180K	1%	28
2013 Q2	$2.21M	Buy	+27,050	New	+$2.02M	1.07%	23

Other funds holding ELV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MIHAS

Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Narwhal Capital Management's ELV Position: Q2 2026 in Review

Narwhal Capital Management reduced its Elevance Health (ELV) stake by 64% in Q2 2026, selling an estimated $351K and leaving 532 shares worth $206K. The position accounts for 0.01% of the portfolio, ranked #153.

Narwhal Capital Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.29M in Q3 2018. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Narwhal Capital Management held 532 shares of Elevance Health worth $206K as of Q2 2026.
Narwhal Capital Management sold 946 Elevance Health shares in Q2 2026, an estimated $351K.
Elevance Health made up 0.01% of Narwhal Capital Management's portfolio in Q2 2026, its #153 holding.
Narwhal Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
Narwhal Capital Management's Elevance Health position peaked at $5.29M in Q3 2018.
417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Narwhal Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.